-
Mashup Score: 1Digitalis in heart failure: declining use and ongoing outcome trials - 10 month(s) ago
Digitalis glycosides (digoxin and digitoxin) are the oldest drugs in cardiovascular (CV) medicine and have generally been used in patients with heart failure (H
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1Amiodarone Versus Digoxin for Acute Rate Control of Atrial Fibrillation in the Emergency Department - REBEL EM - Emergency Medicine Blog - 1 year(s) ago
What is the effectiveness of IV amiodarone vs IV digoxin used as second line therapy in critically ill emergency department patients with atrial fibrillation/flutter where first-line BB use has failed?
Categories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 11
Annals of Clinical Cardiology, Indian Association of Clinical Cardiologists
Source: onlineacc.orgCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 3
Annals of Clinical Cardiology, Indian Association of Clinical Cardiologists
Source: onlineacc.orgCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 10deleterious interaction between omecamtiv mecarbil and atrial fibrillation in patients with heart failure: an influence of digoxin? - 2 year(s) ago
This editorial refers to âInfluence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trialâ, by S.D. Solomo
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
A deleterious interaction between #OmecamtivMecarbil and Afib in patients with HF: an influence of #digoxin? Both trials will enrol HF patients in sinus rhythm and in AF, and these two trials will provide an answer to the current place of digitalis in HF https://t.co/pon1MuhZ6E https://t.co/1Yfsntj5Ok
-
-
Mashup Score: 3Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…
Source: lww.comCategories: Emergency Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…
Source: lww.comCategories: Emergency Medicine, Latest HeadlinesTweet
-
Mashup Score: 0
In the 2021 heart failure guidelines from the European Society of Cardiology, there is a striking difference in the recommendations for the use of sodium-glucose cotransporter 2 (SGLT2) inhibitors and digoxin. SGLT2 inhibitors have a class IA recommendation, and their use is strongly advocated for all patients with heart failure and a reduced ejection fraction (HFrEF). In contrast, digoxin…
Source: Journal of Cardiac FailureCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Digoxin targets low density lipoprotein receptor-related protein 4 and protects against osteoarthritis - 2 year(s) ago
Objectives Dysregulated chondrocyte metabolism is closely associated with the pathogenesis of osteoarthritis (OA). Suppressing chondrocyte catabolism to restore cartilage homeostasis has been extensively explored, whereas far less effort has been invested toward enhancing chondrocyte anabolism. This study aimed to repurpose clinically approved drugs as potential stimulators of chondrocyte…
Source: Annals of the Rheumatic DiseasesCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0JNCCN 360 - Thyroid - Can Digoxin Improve RAI Sensitivity in Resistant Nonmedullary Thyroid Cancer? - 3 year(s) ago
By: Susan Reckling Posted: Monday, February 22, 2021 Although patients with nonmedullary thyroid cancer are often treated with radioactive iodide (RAI), some experience tumor dedifferentiation, with subsequent resistance to such therapy. In the continued search for an effective treatment for these patients,…
Source: jnccn360.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Digitalis in heart failure: declining use and ongoing outcome trials. #EHJ https://t.co/kct9TLUyFU #digoxin #HF #AF #trials #outcome #cardiotwitter @escardio @ESC_Journals https://t.co/LPsapg6TY4